Neval Özkaya

1.6k total citations
26 papers, 724 citations indexed

About

Neval Özkaya is a scholar working on Physiology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Neval Özkaya has authored 26 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Pathology and Forensic Medicine and 9 papers in Immunology. Recurrent topics in Neval Özkaya's work include Histiocytic Disorders and Treatments (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Neval Özkaya is often cited by papers focused on Histiocytic Disorders and Treatments (11 papers), Lymphoma Diagnosis and Treatment (8 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Neval Özkaya collaborates with scholars based in United States, France and Germany. Neval Özkaya's co-authors include Ahmet Doǧan, Omar Abdel‐Wahab, Benjamin H. Durham, Eli L. Diamond, Marc K. Rosenblum, David M. Hyman, Raajit K. Rampal, Gary A. Ulaner, Mario E. Lacouture and Lynn A. Brody and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Neval Özkaya

24 papers receiving 708 citations

Peers

Countries citing papers authored by Neval Özkaya

Since Specialization

Citations

This map shows the geographic impact of Neval Özkaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neval Özkaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neval Özkaya more than expected).

Fields of papers citing papers by Neval Özkaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neval Özkaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neval Özkaya. The network helps show where Neval Özkaya may publish in the future.

Co-authorship network of co-authors of Neval Özkaya

This figure shows the co-authorship network connecting the top 25 collaborators of Neval Özkaya. A scholar is included among the top collaborators of Neval Özkaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neval Özkaya. Neval Özkaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current Concepts in Histiocytic Neoplasms 2025 ·Advances in Anatomic Pathology ·Neval Özkaya, Elaine S. Jaffe	0
2	Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms 2024 ·Blood Advances ·Neval Özkaya, (unknown), Girish Venkataraman, Laszlo J. Karai, Sylvie Fraïtag, (unknown), Stefania Pittaluga, Maxime Battistella, (unknown), F. Le Pelletier, Liqiang Xi, Philippe Moreau, (unknown), Zofia Hélias‐Rodzewicz, Jean Donadieu, (unknown), Mark Raffeld, Elaine S. Jaffe, Jean‐François Emile	6
3	Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach 2023 ·Blood ·Catalina Amador, Dennis D. Weisenburger, Ana Gomez, Alyssa Bouska, Francisco Vega, James R. Cook, Timothy C. Greiner, Andrew L. Feldman, Elaine S. Jaffe, Sarah L. Ondrejka, German Ott, Neval Özkaya, Philipp W. Raess, Andreas Rosenwald, Kerry J. Savage, Graham W. Slack, Joo Y. Song, Lisa M. Rimsza, Wing C. Chan, Javeed Iqbal	1
4	A RUNX1-FPDMM rhesus macaque model reproduces the human phenotype and predicts challenges to curative gene therapies 2022 ·Blood ·Byung‐Chul Lee, Yifan Zhou, Erica Bresciani, Neval Özkaya, (unknown), Blake Carrington, Tae–Hoon Shin, Valentina Baena, Zulfeqhar A. Syed, So Gun Hong, Tao Zhen, Katherine R. Calvo, Paul Liu, Cynthia E. Dunbar	6
5	Localized Peritumoral AL Amyloidosis Associated With Mantle Cell Lymphoma With Plasmacytic Differentiation 2021 ·The American Journal of Surgical Pathology ·Mariko Yabe, Neval Özkaya, Daphne de Jong, Umut Aypar, Maria Stella Ritorto, Ellis Barbé, (unknown), Filiz Şen, (unknown), Heather Landau, Ahmet Doǧan	2
6	Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma 2020 ·Blood Cancer Journal ·Mariko Yabe, Qi Gao, Neval Özkaya, Sarah Huet, Natasha Lewis, Janine Pichardo, Alison J. Moskowitz, Steven M. Horwitz, Ahmet Doǧan, Mikhail Roshal	12
7	Neurological manifestations of Erdheim–Chester Disease 2020 ·Annals of Clinical and Translational Neurology ·Louisa C. Boyd, Kevin O’Brien, Neval Özkaya, Tanya Lehky, Avner Meoded, Bernadette R. Gochuico, Fady Hannah‐Shmouni, Avindra Nath, Camilo Toro, William A. Gahl, Juvianee Estrada‐Veras, Rahul Dave	20
8	T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma 2020 ·Blood Advances ·Paola Ghione, (unknown), Neha Mehta–Shah, Venkatraman Seshan, Neval Özkaya, Shakthi Bhaskar, (unknown), Michael A. Spinner, Matthew A. Lunning, Giorgio Inghirami, Alison J. Moskowitz, Natasha Galasso, Nivetha Ganesan, Carrie van der Weyden, Jia Ruan, H. Miles Prince, Judith Trotman, Ranjana H. Advani, Ahmet Doǧan, Steven M. Horwitz	56
9	Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms 2020 ·Blood Advances ·Natasha Lewis, Kseniya Petrova‐Drus, Sarah Huet, Zachary D. Epstein‐Peterson, Qi Gao, (unknown), Jeeyeon Baik, Neval Özkaya, Alison J. Moskowitz, Anita Kumar, Steven M. Horwitz, Yanming Zhang, Maria E. Arcila, Ross L. Levine, Mikhail Roshal, Ahmet Doǧan, Wenbin Xiao	66
10	Efficacy of MEK inhibition in patients with histiocytic neoplasms 2019 ·Nature ·Eli L. Diamond, Benjamin H. Durham, Gary A. Ulaner, Esther Drill, Justin J. Buthorn, Michelle Ki, Lillian Bitner, Hanna Cho, Robert J. Young, Jasmine H. Francis, Raajit K. Rampal, Mario E. Lacouture, Lynn A. Brody, Neval Özkaya, Ahmet Doǧan, Neal Rosen, Alexia Iasonos, Omar Abdel‐Wahab, David M. Hyman	228
11	Single-agent dabrafenib for BRAF ^V600E -mutated histiocytosis 2018 ·Haematologica ·Ankush Bhatia, Gary A. Ulaner, Raajit K. Rampal, David M. Hyman, Omar Abdel‐Wahab, Benjamin H. Durham, Ahmet Doǧan, Neval Özkaya, Mario E. Lacouture, Julio Hajdenberg, Chezi Ganzel, Eli L. Diamond	33
12	Peripheral T-cell lymphoma – are we making progress? 2018 ·Best Practice & Research Clinical Haematology ·Niloufer Khan, Neval Özkaya, Alison J. Moskowitz, Ahmet Doǧan, Steven M. Horwitz	7
13	AB1144 Histology of rosai-dorfman disease in a subset of patients with erdheim-chester disease: a distinct entity mainly driven by map2k1 2018 ·Annals of the Rheumatic Diseases ·Jérôme Razanamahery, Eli L. Diamond, Fleur Cohen‐Aubart, (unknown), Frédéric Charlotte, Zofia Hélias‐Rodzewicz, Ahmet Doǧan, Omar Abdel‐Wahab, Benjamin H. Durham, Neval Özkaya, Zahir Amoura, Jean‐François Emile, Julien Haroche	1
14	Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1. 2018 ·Journal of Clinical Oncology ·Jérôme Razanamahery, Eli L. Diamond, Karl-Heinz Plate, Frédéric Charlotte, Zofia Hélias‐Rodzewicz, Ahmet Doǧan, Omar Abdel‐Wahab, Benjamin H. Durham, Neval Özkaya, Zahir Amoura, Jean‐François Emile, Julien Haroche	2
15	The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort 2017 ·Modern Pathology ·Neval Özkaya, Marc K. Rosenblum, Benjamin H. Durham, Janine Pichardo, Omar Abdel‐Wahab, Meera Hameed, Klaus J. Busam, William D. Travis, Eli L. Diamond, Ahmet Doǧan	91
16	Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms 2017 ·Hematology/Oncology Clinics of North America ·Neval Özkaya, Ahmet Doǧan, Omar Abdel‐Wahab	13
17	A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease 2017 ·Nature ·Elvira Mass, Christian E. Jacome-Galarza, Thomas Blank, Tomi Lazarov, Benjamin H. Durham, Neval Özkaya, Alessandro Pastore, Marius Schwabenland, Young Rock Chung, Marc K. Rosenblum, Marco Prinz, Omar Abdel‐Wahab, Frédéric Geissmann	130
18	Acute leukaemia with a pure erythroid phenotype: under‐recognized morphological and cytogenetic signatures associated universally with primary refractory disease and a dismal clinical outcome 2017 ·Histopathology ·David C. Park, Neval Özkaya, Scott B. Lovitch	2
19	Discrepancies in Lymphoma Diagnosis Over the Years: A 13-Year Experience in a Tertiary Center 2016 ·Turkish Journal of Hematology ·Neval Özkaya, (unknown), (unknown), Nükhet Tüzüner	6
20	Association of MHC-II, PD-L1, and FoxP3 with Disease Status and Outcomes in Patients with Hodgkin Lymphoma 2016 ·Blood ·Santosha A. Vardhana, Neval Özkaya, Eri Matsuki, Janine Pichardo, Alison J. Moskowitz, David J. Straus, Amanda Copeland, Ai Ni, Achim A. Jungbluth, Craig H. Moskowitz, Ahmet Doǧan, Anas Younes	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact